SER vs TT · rev $56.0K vs P/E 36, rev $21.32B
Serina Therapeutics Inc (SER) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
SER currently screens at market cap $29.7M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the SER and TT stock pages for the full models.
Not investment advice.